Given the rapid systemic clearance of DARPins, which is a downside of the small molecular weight, in future experiments, the effect of half-life extending moieties, such as PEG or an albumin-binding domain [64,65], should be explored for prolonging the plasma half-life, potentially leading to a higher tumor accumulation and greater efficacy. Here, ALB is linked to neoplasm.